NA
GOSS icon

Neuburgh Advisers’s Gossamer Bio GOSS Stock Holding History

Neuburgh Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$708K Buy
42,174
+24,574
+140% +$489K 0.02% 388
2019
Q2 		$390K Sell
17,600
-2,728
-13% -$52.2K 0.01% 519
2019
Q1 		$441K Buy
+20,328
New +$424K 0.02% 481

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neuburgh Advisers's GOSS Position: Q3 2019 in Review

Neuburgh Advisers increased its Gossamer Bio (GOSS) stake by 140% in Q3 2019, buying an estimated $489K and bringing the position to 42,174 shares worth $708K. The position accounts for 0.02% of the portfolio, ranked #388.

Neuburgh Advisers first reported a position in GOSS in Q1 2019 and has held it in 3 quarters since. 79 funds tracked by Wall St. Rank hold GOSS as of Q3 2019.

  • Neuburgh Advisers held 42,174 shares of Gossamer Bio worth $708K as of Q3 2019.
  • Neuburgh Advisers bought 24,574 Gossamer Bio shares in Q3 2019, an estimated $489K.
  • Gossamer Bio made up 0.02% of Neuburgh Advisers's portfolio in Q3 2019, its #388 holding.
  • Neuburgh Advisers first reported a position in Gossamer Bio in Q1 2019 and has held it in 3 quarters since.
  • 79 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.